{"id":"W2999136960","doi":"10.1016/j.annonc.2019.10.022","title":"Vemurafenib in non-small-cell lung cancer patients with BRAFV600 and BRAFnonV600 mutations","year":2020,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":189,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"PharmaMar; Direction Générale de l’offre de Soins; Institut National Du Cancer; Chugai Pharmaceutical; Roche; Fondation ARC pour la Recherche sur le Cancer; Agence Nationale de la Recherche; Novartis; Amgen; Pfizer; CNIB; AbbVie; Merck","keywords":"Vemurafenib; Medicine; Internal medicine; Oncology; Cohort; Lung cancer; Trametinib; Dabrafenib; Cancer; Metastatic melanoma","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002129343,0.0001730329,0.0004244982,0.0001700323,0.0001899292,0.0004327612,0.0001644476,0.0002915498,0.001240245],"category_scores_gemma":[0.0006742952,0.0001128754,0.0004721255,0.0001760696,0.0001003455,0.0003726393,0.0002057061,0.0005974142,0.0001042036],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003396128,"about_ca_system_score_gemma":0.0003295097,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007395053,"about_ca_topic_score_gemma":0.003026908,"domain_scores_codex":[0.9998499,0.00003889731,0.00001630455,0.00002310089,0.00002603813,0.00004569711],"domain_scores_gemma":[0.9998479,0.00004506031,0.00003271514,0.000004664849,0.00001330075,0.00005633489],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.05095807,0.001017639,0.577501,0.001067761,0.001655537,0.003400069,0.0002157507,0.001960191,0.01663614,0.0007557345,0.006455668,0.3383764],"study_design_scores_gemma":[0.003859452,0.009158689,0.9465662,0.0002214872,0.001737864,0.007924647,0.0006465715,0.004816454,0.004393498,0.001276471,0.01933339,0.00006529353],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9829724,0.01220109,0.0001784389,0.0007858335,0.0001698858,0.00002817031,0.0001847166,0.00001691564,0.003462586],"genre_scores_gemma":[0.9980561,0.001084581,0.00006817135,0.0001301015,0.00004992624,0.000009996299,0.0001371936,0.000001675016,0.0004623166],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001240245,"threshold_uncertainty_score":0.004149079,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02275642131417564,"score_gpt":0.2925721636425658,"score_spread":0.2698157423283902,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}